Lupin Ltd. Launches Generic Trizivir® Tablets In The US

Pharma Major Lupin Limited announced today that its US subsidiary Lupin Pharmaceuticals Inc. has launched its Abacavir Sulfate, Lamivudine, and Zidovudine Tablets, 300 mg / 150 mg / 300 mg in the US after the US District Court for the District of Delaware ruled that the Lupin's generic version of TrizivirA did not infringe on patents.

http://www.biospace.com/news_story.aspx?StoryID=319002&full=1